“CRCs enable collaborations that wouldn’t otherwise exist ...”

Professor Terry O’Brien from the University of Melbourne and Royal Melbourne Hospital was interviewed this month on 666 ABC Local Radio, Canberra, about the CRCBID project trialling the use of flumazenil (FMZ) to assist in surgical planning for patients with refractory epilepsy.

FMZ-PET scan pinpoints the site of seizure onset in a patient with temporal lobe epilepsy – image courtesy Professor Terry O’Brien

For a copy of the audio file of the interview, contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it .